img

Global Intramuscular Vaccine Adjuvants Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intramuscular Vaccine Adjuvants Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
Intramuscular Vaccine Adjuvants report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intramuscular Vaccine Adjuvants market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Research Applications and Commercial Applications are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Intramuscular Vaccine Adjuvants industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Intramuscular Vaccine Adjuvants key manufacturers include GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health and Associated British Foods, etc. GSK, Dynavax Technologies, Novavax are top 3 players and held % sales share in total in 2022.
Intramuscular Vaccine Adjuvants can be divided into Infectious Diseases, Cancer and Others,, etc. Infectious Diseases is the mainstream product in the market, accounting for % sales share globally in 2022.
Intramuscular Vaccine Adjuvants is widely used in various fields, such as Research Applications and Commercial Applications, etc. Research Applications provides greatest supports to the Intramuscular Vaccine Adjuvants industry development. In 2022, global % sales of Intramuscular Vaccine Adjuvants went into Research Applications filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intramuscular Vaccine Adjuvants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
Segment by Type
Infectious Diseases
Cancer
Others

Segment by Application


Research Applications
Commercial Applications

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intramuscular Vaccine Adjuvants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intramuscular Vaccine Adjuvants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intramuscular Vaccine Adjuvants industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Intramuscular Vaccine Adjuvants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intramuscular Vaccine Adjuvants introduction, etc. Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Intramuscular Vaccine Adjuvants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Intramuscular Vaccine Adjuvants Market Overview
1.1 Intramuscular Vaccine Adjuvants Product Overview
1.2 Intramuscular Vaccine Adjuvants Market Segment by Type
1.2.1 Infectious Diseases
1.2.2 Cancer
1.2.3 Others
1.3 Global Intramuscular Vaccine Adjuvants Market Size by Type
1.3.1 Global Intramuscular Vaccine Adjuvants Market Size Overview by Type (2024-2034)
1.3.2 Global Intramuscular Vaccine Adjuvants Historic Market Size Review by Type (2024-2024)
1.3.3 Global Intramuscular Vaccine Adjuvants Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intramuscular Vaccine Adjuvants Sales Breakdown by Type (2024-2024)
1.4.2 Europe Intramuscular Vaccine Adjuvants Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Intramuscular Vaccine Adjuvants Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Intramuscular Vaccine Adjuvants Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Intramuscular Vaccine Adjuvants Sales Breakdown by Type (2024-2024)
2 Global Intramuscular Vaccine Adjuvants Market Competition by Company
2.1 Global Top Players by Intramuscular Vaccine Adjuvants Sales (2024-2024)
2.2 Global Top Players by Intramuscular Vaccine Adjuvants Revenue (2024-2024)
2.3 Global Top Players by Intramuscular Vaccine Adjuvants Price (2024-2024)
2.4 Global Top Manufacturers Intramuscular Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intramuscular Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Intramuscular Vaccine Adjuvants Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Intramuscular Vaccine Adjuvants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular Vaccine Adjuvants as of 2022)
2.7 Date of Key Manufacturers Enter into Intramuscular Vaccine Adjuvants Market
2.8 Key Manufacturers Intramuscular Vaccine Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intramuscular Vaccine Adjuvants Status and Outlook by Region
3.1 Global Intramuscular Vaccine Adjuvants Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Intramuscular Vaccine Adjuvants Historic Market Size by Region
3.2.1 Global Intramuscular Vaccine Adjuvants Sales in Volume by Region (2024-2024)
3.2.2 Global Intramuscular Vaccine Adjuvants Sales in Value by Region (2024-2024)
3.2.3 Global Intramuscular Vaccine Adjuvants Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Intramuscular Vaccine Adjuvants Forecasted Market Size by Region
3.3.1 Global Intramuscular Vaccine Adjuvants Sales in Volume by Region (2024-2034)
3.3.2 Global Intramuscular Vaccine Adjuvants Sales in Value by Region (2024-2034)
3.3.3 Global Intramuscular Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Intramuscular Vaccine Adjuvants by Application
4.1 Intramuscular Vaccine Adjuvants Market Segment by Application
4.1.1 Research Applications
4.1.2 Commercial Applications
4.2 Global Intramuscular Vaccine Adjuvants Market Size by Application
4.2.1 Global Intramuscular Vaccine Adjuvants Market Size Overview by Application (2024-2034)
4.2.2 Global Intramuscular Vaccine Adjuvants Historic Market Size Review by Application (2024-2024)
4.2.3 Global Intramuscular Vaccine Adjuvants Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intramuscular Vaccine Adjuvants Sales Breakdown by Application (2024-2024)
4.3.2 Europe Intramuscular Vaccine Adjuvants Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Intramuscular Vaccine Adjuvants Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Intramuscular Vaccine Adjuvants Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Intramuscular Vaccine Adjuvants Sales Breakdown by Application (2024-2024)
5 North America Intramuscular Vaccine Adjuvants by Country
5.1 North America Intramuscular Vaccine Adjuvants Historic Market Size by Country
5.1.1 North America Intramuscular Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2024)
5.1.3 North America Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2024)
5.2 North America Intramuscular Vaccine Adjuvants Forecasted Market Size by Country
5.2.1 North America Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2034)
5.2.2 North America Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2034)
6 Europe Intramuscular Vaccine Adjuvants by Country
6.1 Europe Intramuscular Vaccine Adjuvants Historic Market Size by Country
6.1.1 Europe Intramuscular Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2024)
6.1.3 Europe Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2024)
6.2 Europe Intramuscular Vaccine Adjuvants Forecasted Market Size by Country
6.2.1 Europe Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2034)
6.2.2 Europe Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2034)
7 Asia-Pacific Intramuscular Vaccine Adjuvants by Region
7.1 Asia-Pacific Intramuscular Vaccine Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Intramuscular Vaccine Adjuvants Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Intramuscular Vaccine Adjuvants Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Intramuscular Vaccine Adjuvants Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Intramuscular Vaccine Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Intramuscular Vaccine Adjuvants Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Intramuscular Vaccine Adjuvants Sales in Value by Region (2024-2034)
8 Latin America Intramuscular Vaccine Adjuvants by Country
8.1 Latin America Intramuscular Vaccine Adjuvants Historic Market Size by Country
8.1.1 Latin America Intramuscular Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2024)
8.1.3 Latin America Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2024)
8.2 Latin America Intramuscular Vaccine Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2034)
8.2.2 Latin America Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2034)
9 Middle East and Africa Intramuscular Vaccine Adjuvants by Country
9.1 Middle East and Africa Intramuscular Vaccine Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Intramuscular Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Intramuscular Vaccine Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Intramuscular Vaccine Adjuvants Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Intramuscular Vaccine Adjuvants Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.1.4 GSK Intramuscular Vaccine Adjuvants Products Offered
10.1.5 GSK Recent Development
10.2 Dynavax Technologies
10.2.1 Dynavax Technologies Company Information
10.2.2 Dynavax Technologies Introduction and Business Overview
10.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Dynavax Technologies Intramuscular Vaccine Adjuvants Products Offered
10.2.5 Dynavax Technologies Recent Development
10.3 Novavax
10.3.1 Novavax Company Information
10.3.2 Novavax Introduction and Business Overview
10.3.3 Novavax Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Novavax Intramuscular Vaccine Adjuvants Products Offered
10.3.5 Novavax Recent Development
10.4 Agenus
10.4.1 Agenus Company Information
10.4.2 Agenus Introduction and Business Overview
10.4.3 Agenus Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Agenus Intramuscular Vaccine Adjuvants Products Offered
10.4.5 Agenus Recent Development
10.5 Croda International
10.5.1 Croda International Company Information
10.5.2 Croda International Introduction and Business Overview
10.5.3 Croda International Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Croda International Intramuscular Vaccine Adjuvants Products Offered
10.5.5 Croda International Recent Development
10.6 Seppic
10.6.1 Seppic Company Information
10.6.2 Seppic Introduction and Business Overview
10.6.3 Seppic Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Seppic Intramuscular Vaccine Adjuvants Products Offered
10.6.5 Seppic Recent Development
10.7 OZ Biosciences
10.7.1 OZ Biosciences Company Information
10.7.2 OZ Biosciences Introduction and Business Overview
10.7.3 OZ Biosciences Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.7.4 OZ Biosciences Intramuscular Vaccine Adjuvants Products Offered
10.7.5 OZ Biosciences Recent Development
10.8 Phibro Animal Health
10.8.1 Phibro Animal Health Company Information
10.8.2 Phibro Animal Health Introduction and Business Overview
10.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Phibro Animal Health Intramuscular Vaccine Adjuvants Products Offered
10.8.5 Phibro Animal Health Recent Development
10.9 Associated British Foods
10.9.1 Associated British Foods Company Information
10.9.2 Associated British Foods Introduction and Business Overview
10.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Associated British Foods Intramuscular Vaccine Adjuvants Products Offered
10.9.5 Associated British Foods Recent Development
10.10 InvivoGen
10.10.1 InvivoGen Company Information
10.10.2 InvivoGen Introduction and Business Overview
10.10.3 InvivoGen Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.10.4 InvivoGen Intramuscular Vaccine Adjuvants Products Offered
10.10.5 InvivoGen Recent Development
10.11 Merck KGaA
10.11.1 Merck KGaA Company Information
10.11.2 Merck KGaA Introduction and Business Overview
10.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Merck KGaA Intramuscular Vaccine Adjuvants Products Offered
10.11.5 Merck KGaA Recent Development
10.12 CSL Limited
10.12.1 CSL Limited Company Information
10.12.2 CSL Limited Introduction and Business Overview
10.12.3 CSL Limited Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2024-2024)
10.12.4 CSL Limited Intramuscular Vaccine Adjuvants Products Offered
10.12.5 CSL Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intramuscular Vaccine Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intramuscular Vaccine Adjuvants Industrial Chain Analysis
11.4 Intramuscular Vaccine Adjuvants Market Dynamics
11.4.1 Intramuscular Vaccine Adjuvants Industry Trends
11.4.2 Intramuscular Vaccine Adjuvants Market Drivers
11.4.3 Intramuscular Vaccine Adjuvants Market Challenges
11.4.4 Intramuscular Vaccine Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intramuscular Vaccine Adjuvants Distributors
12.3 Intramuscular Vaccine Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Infectious Diseases
Table 2. Major Company of Cancer
Table 3. Major Company of Others
Table 4. Global Intramuscular Vaccine Adjuvants Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (K Units)
Table 6. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US& Million)
Table 8. Global Intramuscular Vaccine Adjuvants Market Share in Value by Type (2024-2024)
Table 9. Global Intramuscular Vaccine Adjuvants Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2034) & (K Units)
Table 11. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type (2024-2034)
Table 14. Global Intramuscular Vaccine Adjuvants Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (K Units)
Table 16. North America Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2024-2024)
Table 18. Europe Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2024-2024)
Table 22. Latin America Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Intramuscular Vaccine Adjuvants Sales by Company (2024-2024) & (K Units)
Table 26. Global Intramuscular Vaccine Adjuvants Sales Share by Company (2024-2024)
Table 27. Global Intramuscular Vaccine Adjuvants Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Intramuscular Vaccine Adjuvants Revenue Share by Company (2024-2024)
Table 29. Global Market Intramuscular Vaccine Adjuvants Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Intramuscular Vaccine Adjuvants Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Intramuscular Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular Vaccine Adjuvants as of 2022)
Table 33. Date of Key Manufacturers Enter into Intramuscular Vaccine Adjuvants Market
Table 34. Key Manufacturers Intramuscular Vaccine Adjuvants Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Intramuscular Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Intramuscular Vaccine Adjuvants Sales by Region (2024-2024) & (K Units)
Table 38. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Intramuscular Vaccine Adjuvants Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Intramuscular Vaccine Adjuvants Sales Market Share in Value by Region (2024-2024)
Table 41. Global Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (K Units)
Table 43. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Intramuscular Vaccine Adjuvants Sales Market Share in Value by Region (2024-2034)
Table 46. Global Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Intramuscular Vaccine Adjuvants Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (K Units)
Table 49. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application (2024-2024)
Table 52. Global Intramuscular Vaccine Adjuvants Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2034) & (K Units)
Table 54. Global Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application (2024-2034)
Table 57. Global Intramuscular Vaccine Adjuvants Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) (K Units)
Table 59. North America Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) (K Units)
Table 61. Europe Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) (K Units)
Table 65. Latin America Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (K Units)
Table 69. North America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2024)
Table 72. North America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 73. North America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (K Units)
Table 77. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 81. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. GSK Intramuscular Vaccine Adjuvants Product
Table 112. GSK Recent Development
Table 113. Dynavax Technologies Company Information
Table 114. Dynavax Technologies Introduction and Business Overview
Table 115. Dynavax Technologies Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Dynavax Technologies Intramuscular Vaccine Adjuvants Product
Table 117. Dynavax Technologies Recent Development
Table 118. Novavax Company Information
Table 119. Novavax Introduction and Business Overview
Table 120. Novavax Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Novavax Intramuscular Vaccine Adjuvants Product
Table 122. Novavax Recent Development
Table 123. Agenus Company Information
Table 124. Agenus Introduction and Business Overview
Table 125. Agenus Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Agenus Intramuscular Vaccine Adjuvants Product
Table 127. Agenus Recent Development
Table 128. Croda International Company Information
Table 129. Croda International Introduction and Business Overview
Table 130. Croda International Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Croda International Intramuscular Vaccine Adjuvants Product
Table 132. Croda International Recent Development
Table 133. Seppic Company Information
Table 134. Seppic Introduction and Business Overview
Table 135. Seppic Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Seppic Intramuscular Vaccine Adjuvants Product
Table 137. Seppic Recent Development
Table 138. OZ Biosciences Company Information
Table 139. OZ Biosciences Introduction and Business Overview
Table 140. OZ Biosciences Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. OZ Biosciences Intramuscular Vaccine Adjuvants Product
Table 142. OZ Biosciences Recent Development
Table 143. Phibro Animal Health Company Information
Table 144. Phibro Animal Health Introduction and Business Overview
Table 145. Phibro Animal Health Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Phibro Animal Health Intramuscular Vaccine Adjuvants Product
Table 147. Phibro Animal Health Recent Development
Table 148. Associated British Foods Company Information
Table 149. Associated British Foods Introduction and Business Overview
Table 150. Associated British Foods Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Associated British Foods Intramuscular Vaccine Adjuvants Product
Table 152. Associated British Foods Recent Development
Table 153. InvivoGen Company Information
Table 154. InvivoGen Introduction and Business Overview
Table 155. InvivoGen Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. InvivoGen Intramuscular Vaccine Adjuvants Product
Table 157. InvivoGen Recent Development
Table 158. Merck KGaA Company Information
Table 159. Merck KGaA Introduction and Business Overview
Table 160. Merck KGaA Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Merck KGaA Intramuscular Vaccine Adjuvants Product
Table 162. Merck KGaA Recent Development
Table 163. CSL Limited Company Information
Table 164. CSL Limited Introduction and Business Overview
Table 165. CSL Limited Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. CSL Limited Intramuscular Vaccine Adjuvants Product
Table 167. CSL Limited Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Intramuscular Vaccine Adjuvants Market Trends
Table 171. Intramuscular Vaccine Adjuvants Market Drivers
Table 172. Intramuscular Vaccine Adjuvants Market Challenges
Table 173. Intramuscular Vaccine Adjuvants Market Restraints
Table 174. Intramuscular Vaccine Adjuvants Distributors List
Table 175. Intramuscular Vaccine Adjuvants Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Intramuscular Vaccine Adjuvants Product Picture
Figure 2. Global Intramuscular Vaccine Adjuvants Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Intramuscular Vaccine Adjuvants Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Intramuscular Vaccine Adjuvants Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Infectious Diseases
Figure 6. Global Infectious Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Cancer
Figure 8. Global Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type in 2022 & 2034
Figure 13. North America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 14. North America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 15. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 16. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 19. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Intramuscular Vaccine Adjuvants Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Intramuscular Vaccine Adjuvants Revenue in 2022
Figure 25. Intramuscular Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Research Applications
Figure 27. Global Research Applications Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Commercial Applications
Figure 29. Global Commercial Applications Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application in 2022 & 2034
Figure 32. North America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 33. North America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 34. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 35. Europe Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 38. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Intramuscular Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Intramuscular Vaccine Adjuvants Manufacturing Cost Structure
Figure 43. Intramuscular Vaccine Adjuvants Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries